Drug Database
Back to search

Finland· FI-REL-REL63212

SUBLIVAC Koivu

A baumpollen product containing betula verrucosa, registered in Finland by HAL Allergy B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC V01AA05

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedSUBLIVAC KoivuATCV01AA05REGISTER NO.FI-REL-REL63212PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about betula verrucosaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Baumpollen is registered in 12 of 19 countries.

Countries holding a registration under ATC V01AA05 (baumpollen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose
Search baumpollen products by name

Baumpollen · ATC V01AA05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Betula verrucosa
Manufacturer
HAL Allergy B.V.
Country
Finland (FI)
ATC code
V01AA05
ATC class
Baumpollen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Baumpollen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All baumpollen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/37917523-e5fa-4a56-87d0-2c07d014b276
GET /v1/drugs/37917523-e5fa-4a56-87d0-2c07d014b276?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "Tipat suuonteloon, liuos",
  "route": "Suuonteloon",
  "ddd_unit": null,
  "strength": "40000 AUN",
  "atc_label": "puiden siitepölyt",
  "ma_number": "44151",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL63212",
  "authorised_at": "2025-04-25"
}
API referenceMCP serverPlans

See everything about baumpollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console